Advance Search
YAO Min, ZHANG Yan. Application of procalcitonin detection in thyroid diseases[J]. Journal of Clinical Medicine in Practice, 2022, 26(1): 95-98. DOI: 10.7619/jcmp.20212098
Citation: YAO Min, ZHANG Yan. Application of procalcitonin detection in thyroid diseases[J]. Journal of Clinical Medicine in Practice, 2022, 26(1): 95-98. DOI: 10.7619/jcmp.20212098
shu

Application of procalcitonin detection in thyroid diseases

  • Laboratory Department, Jiangdu People′s Hospital of Yangzhou City in Jiangsu Province, Yangzhou, Jiangsu, 225200

More Information
  • Received Date: May 18, 2021
  • Available Online: January 19, 2022
  • Published Date: January 14, 2022
    Graphical Abstract
    • Abstract
  •   Objective  To explore value of procalcitonin (PCT) in diagnosis and differential diagnosis of medullary thyroid carcinoma.
      Methods  A tatal of 277 patients with thyroid nodules diagnosed by ultrasound-guided fine needle aspiration biopsy were selected, including 142 cases of benign nodules, 24 cases of medullary thyroid carcinoma, and 111 cases of non-medullary thyroid carcinoma (61 cases of papillary carcinoma, 30 cases of thyroid follicular carcinoma and 20 cases of undifferentiated carcinoma). Calcitonin (CT), carcinoembryonic antigen (CEA), thyroid stimulating hormone (TSH) and PCT were detected by luminescence method in all the patients.
      Results  The CT level in patients with benign nodules, non-medullary thyroid carcinoma and medullary thyroid carcinoma showed a rising trend, and the differences were statistically significant (P < 0.05 or P < 0.01). The levels of PCT in patients with medullary thyroid carcinoma, benign nodules and non-medullary thyroid carcinoma were (3.10±2.87), (0.20±0.19) and (0.14±0.10) μg/L respectively, and PCT level in patients with medullary thyroid carcinoma was significantly higher than that in patients with benign nodules and non-medullary thyroid carcinoma (P < 0.01). The levels of PCT in patients with thyroid papillary carcinoma, thyroid follicular carcinoma and undifferentiated thyroid carcinoma were (0.18±0.12), (0.07±0.04) and (0.13±0.01) μg/L respectively, and PCT level in patients with medullary thyroid carcinoma was significantly higher than that in patients with papillary thyroid carcinoma, thyroid follicular carcinoma and undifferentiated thyroid carcinoma (P < 0.01). The area under curve (AUC) of PCT in the diagnosis of medullary thyroid carcinoma was 0.978 (95%CI, 0.959 to 0.997) and P value was less than 0.001; when the cut-off value was 1.58 μg/L, the sensitivity and specificity were 99.00% and 98.78%, respectively. The AUC of PCT level in the diagnosis of non-medullary thyroid carcinoma was 0.990 (95%CI, 0.990 to 1.000, P < 0.001); when the cut-off value was 1.66 μg/L, the sensitivity and specificity of PCT in the diagnosis of medullary thyroid carcinoma were 99.10% and 99.90%, respectively.
      Conclusion  When screening medullary thyroid carcinoma in patients with thyroid nodules, PCT is a specific index, which can be used as a supplemented or replaced serum marker to CT. In patients with non-medullary thyroid carcinoma, PCT can also be used as an effective index to distinguish medullary thyroid carcinoma.
    • FullText(HTML)
    • References (17)
  • [1]
    KARAGIANNIS A K, GIRIO-FRAGKOULAKIS C, NAKOUTI T. Procalcitonin: A New Biomarker for Medullary Thyroid Cancer A Systematic Review[J]. Anticancer Res, 2016, 36(8): 3803-3810.
    [2]
    TRIMBOLI P, TREGLIA G, GUIDOBALDI L, et al. Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis[J]. Clin Endocrinol, 2015, 82: 280-285. doi: 10.1111/cen.12563
    [3]
    HAUGEN B R, ALEXANDER E K, BIBLE K C, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1): 1-133. doi: 10.1089/thy.2015.0020
    [4]
    COSTANTE G, DURANTE C, FRANCIS Z, et al. Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls[J]. Nat Clin Pract Endocrinol Metab, 2009, 5(1): 35-44. doi: 10.1038/ncpendmet1023
    [5]
    GHARIB H, PAPINI E, GARBER J R, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules[J]. Endocr Pract, 2016, 22: 622-639.
    [6]
    PINA G, DUBOIS S, MURAT A, et al. Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test[J]. Clin Endocrinol, 2013, 78: 358-364. doi: 10.1111/cen.12001
    [7]
    MIAN C, PERRINO M, COLOMBO C, et al. Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety[J]. J Clin Endocrinol Metab, 2014, 99: 1656-1664. doi: 10.1210/jc.2013-4088
    [8]
    ALGECIRAS-SCHIMNICH A, PREISSNER C M, THEOBALD J P, et al. Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma[J]. J Clin Endocrinol Metab, 2009, 94(3): 861-868. doi: 10.1210/jc.2008-1862
    [9]
    MACHENS A, LORENZ K, DRALLE H. Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer[J]. J Clin Endocrinol Metab, 2014, 99(8): 2986-2994. doi: 10.1210/jc.2014-1278
    [10]
    SCHNEIDER D F, CHEN H. New developments in the diagnosis and treatment of thyroid cancer[J]. CA Cancer J Clin, 2013, 63: 374-394.
    [11]
    CAMACHO C P, LINDSEY S C, MELO M C, et al. Measurement of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullary thyroid cancer and may replace calcitonin-stimulation tests[J]. Thyroid, 2013, 23(3): 308-316. doi: 10.1089/thy.2012.0361
    [12]
    ALGECIRAS-SCHIMNICH A, PREISSNER C M, THEOBALD J P, et al. Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma[J]. J Clin Endocrinol Metab, 2009, 94: 861-868. doi: 10.1210/jc.2008-1862
    [13]
    GIOVANELLA L, VERBURG F A, IMPERIALI M, et al. Comparison of serum calcitonin and procalcitonin in detecting medullary thyroid carcinoma among patients with thyroid nodules[J]. Clin Chem Lab Med, 2013, 51: 1477-1481.
    [14]
    李睿, 熊大迁, 辛力华, 等. 降钙素原对亚急性甲状腺炎合并细菌感染的诊断价值[J]. 西部医学, 2021, 33(10): 1492-1495, 1499. doi: 10.3969/j.issn.1672-3511.2021.10.017
    [15]
    王慧, 刘勤江, 王云生. 甲状腺髓样癌中降钙素和降钙素原的表达及临床意义[J]. 兰州大学学报: 医学版, 2020, 46(4): 25-29. https://www.cnki.com.cn/Article/CJFDTOTAL-LZYX202004006.htm
    [16]
    路晓波, 许延路, 边建平. 重症感染患者血清甲状腺激素及降钙素原水平变化及临床意义[J]. 山东医药, 2020, 60(13): 70-72. doi: 10.3969/j.issn.1002-266X.2020.13.020
    [17]
    胡欣, 韩雪, 陈国芳, 等. 血清降钙素原在甲状腺髓样癌诊断及随访中的临床价值[J]. 临床内科杂志, 2020, 37(1): 69-70. doi: 10.3969/j.issn.1001-9057.2020.01.023
    • Related Articles

  • Related Articles

    [1]ZHANG Haoyun, LI Mengxi, KANG Shujuan, ZHANG Bingjie, LI Xianqiao, SHAN Tieying, LI Hao, LIU Xiaoyan, CUI Zhiqiang. Effects of atorvastatin calcium on thyroid function, immune response and JNK/p38 MAPK signaling pathway in rats with hypothyroidism[J]. Journal of Clinical Medicine in Practice, 2024, 28(16): 49-55. DOI: 10.7619/jcmp.20233518
    [2]LU Yuanjun, LUAN Mei, FU Min, PAN Yumin, LIU Yanxi, SONG Jinling, ZENG Jiantao. Thyroid hormone levels in patients with acute ischemic stroke and non-valvular atrial fibrillation[J]. Journal of Clinical Medicine in Practice, 2024, 28(8): 75-78. DOI: 10.7619/jcmp.20233711
    [3]YANG Zhisen, GENG Li, TIAN Guijin, HAO Nana, LIU Shukai, ZHANG Xiumei. Effects of different doses of iodine-131 on tumor suppressor gene expression, thyroid hormone and chromosomal aberrations in patients after thyroid cancer surgery[J]. Journal of Clinical Medicine in Practice, 2021, 25(17): 88-91, 96. DOI: 10.7619/jcmp.20211901
    [4]CHU Zhaoxin, QIAN Yongxiang, YAN Jianming, CHEN Jie, CHEN Xiangbiao, ZHU Peipei, PU Chenchen, YOU Peijue. Correlations between papillary thyroid carcinoma and indicators including body mass index[J]. Journal of Clinical Medicine in Practice, 2021, 25(13): 64-67. DOI: 10.7619/jcmp.20211081
    [5]WU Jie, WANG Huan, LIANG Changping, WANG Min, HE Tao. Value of serum stimulant thyroglobulin level in the diagnosis and predicting prognosis of differentiated thyroid carcinoma[J]. Journal of Clinical Medicine in Practice, 2021, 25(10): 57-61. DOI: 10.7619/jcmp.20210124
    [6]YANG Qi, FAN Bo, LU Lu. Influence of thyroidectomy on related indicators in patients with thyroid cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(23): 30-32. DOI: 10.7619/jcmp.202023010
    [7]BO Yawen, ZHAO Zhen, YE Xinhua. Intergrated traditional Chinese and western medicine in the treatment of subacute thyroiditis combined with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2020, 24(14): 19-22. DOI: 10.7619/jcmp.202014005
    [8]LIU Ping, MEI Hong. Effect of low-dose hormone on serum soluble triggering receptor expressed on myeloid cells-1, procalcitonin and CD64 in children with sepsis[J]. Journal of Clinical Medicine in Practice, 2017, (15): 41-44,48. DOI: 10.7619/jcmp.201715011
    [9]WANG Xiaohan, ZHANG Ningning. Changes of serum levels of thyroid hormones and blood lipid in patients with varying degrees of Alzheimer's disease and related risk factors[J]. Journal of Clinical Medicine in Practice, 2016, (5): 32-35. DOI: 10.7619/jcmp.201605010
    [10]LI Zhihong. Value of thyroid stimulating hormone inhibition therapy in differentiated thyroid carcinoma[J]. Journal of Clinical Medicine in Practice, 2013, (9): 107-108. DOI: 10.7619/jcmp.201309039

  • Cited by

    Periodical cited type(5)

    1. 尹馨，焦娟，常志红，夏迎龙，刘杰，关坤萍. 外周血白细胞分类模型的建立与应用. 实用临床医药杂志. 2023(03): 86-90 . 本站查看
    2. 桂金杰，刘丽丽，李慧敏，赖丽娟，钟立芳. 心脏远程监护仪监测指标与阻塞性睡眠呼吸暂停低通气综合征严重程度的关系. 中国医学创新. 2023(12): 30-34 .
    3. 曹雨菡，李瑾，何民，王丹，陈伟. 基于ICF冠心病患者远程康复的Scoping综述. 中国康复理论与实践. 2023(04): 433-442 .
    4. 王志娟，谭琛. 基于心电图的人工智能在心脏性猝死中的预警作用. 中国临床医生杂志. 2023(08): 891-894 .
    5. 徐玉娇，邓力威，孙蒙恩，王勇. 健康中国背景下预防大学生运动猝死的理论模式构建. 当代体育科技. 2023(31): 158-161 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (283) PDF downloads (19) Cited by(5)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return